Recent Developments in Geothermal Drilling Fluids

In the past, standard drilling muds have been used to drill most geothermal wells. However, the harsh thermal and chemical environment and the unique geothermal formations have led to such problems as excessive thickening of the fluid, formation damage, and lost circulation. This paper describes three recent development efforts aimed at solving some of these drilling fluid problems. Each of the efforts is at a different stage of development. The Sandia aqueous foam studies are still in the laboratory phase, NL Baroid's polymeric deflocculant is soon to be field tested, and the Mudtech high-temperature mud was field tested several months ago. Low density and the capability to suspend particles at low relative velocities are two factors which make foam an attractive drilling fluid. The stability of these foams and their material properties at high temperatures are presently unknown and this lack of information has precluded their use as a geothermal drilling fluid. The aqueous foam studies being conducted at Sandia are aimed at screening available surfactants for temperature and chemical stability. Approximately 100 surfactants have been tested at temperatures of 260 and 310 C (500 and 590 F), and several of these candidates appear very promising. NL Baroid has developed a polymeric deflocculant for water-based muds which shows promise in retarding thermal degradation effects and associated gelation. Formulations containing this new polymer have shown good rheological properties up to 260 C (500 F) in laboratory testing. A high-temperature mud consisting primarily of sepiolite, bentonite, and brown coal has been developed by Mudtech, Inc. A field test of this mud was conducted in a geothermal well in the Imperial Valley of California in May 1980. The fluid exhibited good hole-cleaning characteristics and good rheological properties throughout the test

The prognostic significance of genetic polymorphisms (Methylenetetrahydrofolate Reductase C677T, Methionine Synthase A2756G, Thymidilate Synthase tandem repeat polymorphism) in multimodally treated oesophageal squamous cell carcinoma

The present study retrospectively examined the correlation between the outcome of patients with locally advanced oesophageal squamous cell carcinoma (cT3-4 cN0-1 cM0) after multimodal treatment (radiochemotherapy±surgical resection), and the presence of genetic polymorphisms in genes involved in folate metabolism. In total, 68 patients who took part in a prospective multicentric trial received 5-fluorouracil (FU)-based radiochemotherapy, optionally followed by surgery. DNA was extracted from pretherapeutic tumour biopsies and was subsequently genotyped for common genetic polymorphisms of three genes (MTHFR C677T, MTR A2756G, TS tandem repeat polymorphism) involved in folate metabolism and potentially in sensitivity to 5-FU-based chemotherapy. The genotypes were correlated with tumour response to polychemotherapy, radiochemotherapy and with overall survival. Tumours with the MTR wild-type genotype (2756AA) showed a median survival time of 16 months, whereas tumours with an MTR variant genotype (2756AG/2756GG) showed a median survival time of 42 months (P=0.0463). No prognostic impact could be verified for the genotypes of the MTHFR genes and the TS gene. Among tumours treated with radiochemotherapy and subsequent resection, MTR variant genotype showed higher histopathological response rate than tumours with MTR wild-type genotype (P=0.0442). In contrast, no significant relationship between clinically determined tumour regression after polychemotherapy and polymorphisms of the three genes under analysis was observed. In conclusion, pretherapeutic determination of the MTR A2756G polymorphism may predict survival of multimodally treated oesophageal squamous cell carcinomas. Determination of MTHFR C677T and TS tandem repeat polymorphism has no predictive value

From taxonomies to ontologies: formalizing generalization knowledge for on-demand mapping

© 2015 Cartography and Geographic Information Society Automation of the cartographic design process is central to the delivery of bespoke maps via the web. In this paper, ontological modeling is used to explicitly represent and articulate the knowledge used in this decision-making process. A use case focuses on the visualization of road traffic accident data as a way of illustrating how ontologies provide a framework by which salient and contextual information can be integrated in a meaningful manner. Such systems are in anticipation of web-based services in which the user knows what they need, but do not have the cartographic ability to get what they want

HIV-1 viral load and CD4 cell count in untreated children with vertically acquired asymptomatic or mild disease. Paediatric European Network for Treatment of AIDS (PENTA).

BACKGROUND: Plasma HIV-1 RNA levels are high in vertically infected infants. Information in older children is limited, particularly in those who have not received antiretroviral therapy. OBJECTIVES: To describe the relationships between HIV-1 RNA, age and CD4 cell count in untreated vertically infected children. DESIGN: HIV-1 RNA was measured in 70 children [median age, 3.5 years (range, 0.4-11.9 years); median CD4 cell count, 881 x 10(6)/l (interquartile range, 576-1347 x 10(6) cells/l)] enrolled in a randomized placebo-controlled trial comparing immediate with deferred zidovudine in asymptomatic or mildly symptomatic vertically infected children (PENTA-1 trial). Short-term variability was assessed by comparing HIV-1 RNA at -2 and 0 weeks (prior to randomization). The relationship between age and HIV-1 RNA, and CD4 cell count was analysed using data from all children prior to randomization and sequential samples from 35 remaining on placebo for up to 105 weeks, by fitting mixed linear models. RESULTS: The within-individual SD in viral load was 0.26 log10 copies/ml. The median plasma HIV-1 RNA at enrollment was 4.61 log10 (range, 2.3-6.56 log10 copies/ml), significantly higher in children aged 2 years (4.51 log10 copies/ml; P < 0.0001). Mean HIV-1 RNA fell by 0.38 log10 copies/ml per year up to 2 years of age, by 0.21 log10 copies/ml per year from 2 to 4 years of age, and by 0.03 log10 copies/ml per year from 4 to 6 years of age reaching a nadir of 4.25 log10 copies/ml at 6 years. Mean log10 CD4 cell count declined steadily with age and was not significantly correlated with HIV-1 RNA, although there was some evidence that the rate of log10 CD4 cell decline was negatively correlated with the initial rate of HIV-1 RNA decline. No mutations associated with resistance to zidovudine were observed. CONCLUSIONS: Age is a key factor in the interpretation of both viral load and CD4 cell count in vertically infected childre